0 NYSE Companies - March 8, 2024INNOVATE Corp. Announces Commencement of Rights OfferingNEW YORK, March 08, 2024 (GLOBE NEWSWIRE) — INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, […]Read More
0 NASDAQ Companies - March 8, 2024Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumCARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today […]Read More
0 TSX Venture News - March 8, 2024Kane Biotech Receives Bioscience Association Manitoba Company of the Year AwardWINNIPEG, Manitoba, March 08, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) […]Read More
0 NASDAQ Companies - March 8, 2024Safe and Green Development Corp Secures Financing for Norman Berry Expansion in Atlanta, GeorgiaMIAMI, Fla, March 08, 2024 (GLOBE NEWSWIRE) — Safe and Green Development Corporation (NASDAQ: SGD)(“SG DevCo” or the “Company”), is […]Read More
0 NYSE Companies - March 8, 2024CVR Partners Provides Update on Availability of 2023 K-1 Tax PackagesSUGAR LAND, Texas, March 08, 2024 (GLOBE NEWSWIRE) — CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea […]Read More
0 NASDAQ Companies - March 8, 2024Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting– Cerebrospinal fluid (CSF) biomarker results are highly supportive of sabirnetug’s downstream pharmacological effects in the brain in early AD […]Read More
0 NASDAQ Companies - March 8, 2024PodcastOne (NASDAQ: PODC) Subsidiary of (NASDAQ: LVO) President and Co-Founder Kit Gray to Present at the 36th Annual ROTH Conference March 17-19, 2024LOS ANGELES, CA, March 08, 2024 (GLOBE NEWSWIRE) — via NewMediaWire –PodcastOne (NASDAQ: PODC), a leading podcast platform and a […]Read More
0 NASDAQ Companies - March 8, 2024Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent HighlightsTopline GSBR-1290 Phase 2a 12-week obesity data, as well as data from formulation bridging and titration optimization study, on track […]Read More
0 Canadian Stock Exchange News - March 8, 2024Discovery Lithium Announces the Commencement of OTCQB TradingVANCOUVER, British Columbia, March 08, 2024 (GLOBE NEWSWIRE) — Discovery Lithium Inc. (OTCQB: DCLIF) (CSE: DCLI) (FRA: Q3Q0) (WKN: A3EFKA) […]Read More
0 NASDAQ Companies - March 8, 2024ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke TherapyRandomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to […]Read More